David Lee Thomas, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 871 Broad St, Summersville, WV 26651 Phone: 304-872-2771 Fax: 304-872-2771 |
Dr. Kevin Charles Lucky, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 832 Broad Street, Summersville, WV 26651 Phone: 304-872-3919 Fax: 304-872-4943 |
Dr. William Howard Mason Ii, DDS Dentist - General Practice Medicare: Medicare Enrolled Practice Location: 415 Main St, Summersville, WV 26651 Phone: 304-872-1663 Fax: 304-872-1804 |
Mason Bishop, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 402 Red Oak St, Summersville, WV 26651 Phone: 304-872-5600 |
Dr. Katherine M Wooton, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 702 Professional Park Dr Ste 100, Summersville, WV 26651 Phone: 304-872-7272 Fax: 304-872-9595 |
Mr. Charles G Riddle, DDS Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 415 Main St, Summersville, WV 26651 Phone: 304-872-1663 Fax: 304-872-1804 |
Dr. Lewis D. Gilbert, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 807 Broad St, Summersville, WV 26651 Phone: 304-872-0300 Fax: 304-872-5999 |
Dr. Robert Rowland Fletcher Ii, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 402 Red Oak St., Summersville, WV 26651 Phone: 304-872-5600 |
News Archive
When stem cell transplant first became part of standard treatment for certain cancers and blood diseases twenty years ago, individuals older than 60 were rarely considered for the procedure.
The Lupus Research Institute today announced the award of 12 new research grants, building on its decade-long commitment to drive innovation and discover novel approaches to understand and treat one of the world's most confounding and elusive diseases - lupus.
Russian scientists successfully tested biodegradable tibia implants with bioactive coatings out of polylactic acid and calcium phosphate, which might shorten the treatment period by two-four times compared to current world standards.
Scarab Genomics, a pioneer in the world of E. coli genomics and production strains, and Lonza, a world leader in biopharmaceutical development and production, announced today the companies have entered into a preferred marketing and sales agreement for Scarab Genomics' Clean Genome E. coli. Financial details of the contract were not disclosed.
› Verified 7 days ago